trending Market Intelligence /marketintelligence/en/news-insights/trending/fryxvkzzphjg4qzlvw-hdq2 content esgSubNav
In This List

Insmed appoints director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Insmed appoints director

Insmed Inc. appointed Leo Lee as a board member.

Lee most recently served as the president of Japan at Merck KGaA.

Bridgewater, N.J.-based Insmed is a biopharmaceutical company, which focuses on the development and commercialization of therapies for patients with rare diseases.